Home/ Stocks/ MRVI

Maravai LifeSciences Holdings, Inc. Class A Common Stock

MRVI XNAS

$4.37 -0.05 (-1.14%) ▼ 15-min delayed

Open

$4.40

High

$4.42

Low

$4.33

Volume

168.0K

Market Cap

$649.03M

About Maravai LifeSciences Holdings, Inc. Class A Common Stock

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 416 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$65.84M	$-6,377,000	$-0.02
FY 2025	$185.74M	$-230,762,000	$-0.90
Q3 2025	$41.63M	$-45,057,000	$-0.18
Q2 2025	$47.40M	$-69,837,000	$-0.27

Earnings & Analyst Ratings

Next Earnings: Mon, Aug 10, 2026

Calendar →

Related Market News

No specific coverage for MRVI yet. Check out our latest market news or earnings calendar.

Get MRVI Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Maravai LifeSciences Holdings, Inc. Class A Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.